4.1 Article

The Efficacy of Glucomannan Supplementation in Overweight and Obesity: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials

Kenneth F. Schulz et al.

PLOS MEDICINE (2010)

Article Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

ANNALS OF INTERNAL MEDICINE (2009)

Article Genetics & Heredity

Obesity: Genetic, molecular, and environmental aspects

Lewis A. Barness et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)

Article Endocrinology & Metabolism

Effect of adding exercise to a diet containing glucomannan

William J. Kraemer et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2007)

Review Gastroenterology & Hepatology

Lifestyle modification for the management of obesity

Thomas A. Wadden et al.

GASTROENTEROLOGY (2007)

Article Nutrition & Dietetics

Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes

M Yoshida et al.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2006)

Article Cardiac & Cardiovascular Systems

Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children

F Martino et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2005)

Article Medicine, General & Internal

Better reporting of harms in randomized trials: An extension of the CONSORT statement

JPA Ioannidis et al.

ANNALS OF INTERNAL MEDICINE (2004)

Article Medicine, Research & Experimental

Statistical considerations in the intent-to-treat principle

JM Lachin

CONTROLLED CLINICAL TRIALS (2000)